This compound is a deuterated pharmaceutical intermediate, specifically a heptadeuterated analog of a propan-2-ylamino derivative. Its significance lies in its use as a building block in the synthesis of deuterated drugs, where the incorporation of deuterium atoms can influence metabolic stability.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N-Methyl-2-(1-methylethyl)-4-thiazolemethanamine dihydrochloride
pharmaceutical intermediate
2-Methyl-N-(phenylmethylene)alanine-d6 Ethyl Ester
pharmaceutical intermediate
Methyl 4-(acetylamino)-5-(ethylsulfonyl)-2-methoxybenzoate
pharmaceutical intermediate
N-Boc-N'-(2-chloro-Cbz)-L-ornithine
pharmaceutical intermediate
Pindolol
pharmaceutical raw material
1-(1,1,1,2,3,3,3-heptadeuteriopropan-2-ylamino)-3-(1H-indol-4-yloxy)propan-2-ol
JZQKKSLKJUAGIC-SVMCCORHSA-N
[2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])NCC(COC1=CC=CC2=C1C=CN2)O
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.